[April 15, 2014] |
|
Research and Markets: Global Dementia Associated With Alzheimer's Disease Pipeline Review Report 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5kd8th/dementia)
has announced the addition of the "Dementia
Associated With Alzheimer's Disease - Pipeline Review, H1 2014"
report to their offering.
This report provides comprehensive information on the therapeutic
development for Dementia Associated With Alzheimer's Disease, complete
with comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and featured news and
press releases. It also reviews key players involved in the therapeutic
development for Dementia Associated With Alzheimer's Disease and special
features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new target and MOAs to produce
first-in-class and best-in-class products.
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Dementia Associated With Alzheimer's Disease
-
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics
development for Dementia Associated With Alzheimer's Disease and
enlists all their major and minor projects
-
The report summarizes all the dormant and discontinued pipeline
projects
-
A review of the Dementia Associated With Alzheimer's Disease products
under development by companies and universities/research institutes
based on information derived from company and industry-specific sources
-
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
A detailed assessment of monotherapy and combination therapy pipeline
projects
-
Coverage of the Dementia Associated With Alzheimer's Disease pipeline
on the basis of target, MoA, route of administration and molecule type
-
Latest news and deals relating related to pipeline products
Dementia Associated With Alzheimer's Disease - Companies Involved in
Therapeutics Development
-
Kowa Company, Ltd.
-
MediPost Co., Ltd.
-
e-Therapeutics plc
-
Adamas Pharmaceuticals, Inc.
-
Chase Pharmaceuticals Corporation
Drug Profiles
-
(memantine hydrochloride ER + donepezil hydrochloride)
-
K-828-AB
-
Neurostem
-
TAK-070
-
ETX-6765
-
CPC (News - Alert)-001
-
erlotinib hydrochloride
-
gefitinib
-
AVCRI-104P3
For more information visit http://www.researchandmarkets.com/research/5kd8th/dementia
[ Back To TMCnet.com's Homepage ]
|